跳至主要内容
临床试验/NCT06747897
NCT06747897已完成不适用

Retrospective Consumer Experience on Former Use of DIPROBASE Advanced Eczema Cream® UI 1613882

Bayer1 个研究点 分布在 1 个国家目标入组 300 人开始时间: 2024年11月28日最近更新:
适应症

试验速览

阶段
不适用
状态
已完成
发起方
Bayer
入组人数
300
试验地点
1
主要终点
Overall intensity of the symptoms

研究概览

简要总结

This is an observational study which means only data are collected from participants about their experience and symptoms, who received their usual treatment without any intervention from the study sponsor.

Atopic dermatitis, also known as eczema, is a long-lasting skin disease that causes redness, swelling, dryness, cracking, and intense itching. Xerosis is the scientific wording to describe dry skin. This condition is caused by a weakened skin barrier that does not hold moisture well.

DIPROBASE® advanced eczema cream is already available for use in the UK. It moisturizes and protects the skin.

This study is being done to understand how people use DIPROBASE® Advanced Eczema Cream and how consistently they adhere to its recommended use in their daily routines. In this study, participants will be asked to fill in an online questionnaire about their eczema symptoms and experience with DIPROBASE® Advanced Eczema Cream.

No treatment advice will be given as a part of this study.

The main purpose of this study is to gather feedback from people in the UK who have used DIPROBASE® Advanced Eczema Cream to treat their eczema or their dry skin condition. To do this, researchers will collect the following information from participants:

  • intensity of eczema symptoms
  • whether the cream provides a cooling or soothing effect
  • whether the cream helps to ease the symptoms like itchiness, pain, or dryness

It is planned to identify and collect user data from November 2024 to January 2025. Participants will be recruited through a consumer database available with an external partner or via social media.

In this study, only data are collected. No visits or tests are required as part of this study.

研究设计

研究类型
Observational
观察模型
Cohort
时间视角
Retrospective

入排标准

年龄范围
18 Years 至 —(Adult, Older Adult)
性别
All
接受健康志愿者

入选标准

  • Participants:
  • Biological sex: M/F.
  • Age: > or equal to 18 years of age.
  • Mothers, fathers, grandparents, and other caregivers aged 18 years of age and above, who will report data on themselves, their children from 2 to 12 years of age or their infants under 2 years of age.
  • Able to read and understand the language of the online questionnaire.
  • Have used the product within the previous three (3) months.
  • Agree that the data collected can be used for research, marketing and regulatory purposes.

排除标准

  • Due to the real-world nature of the study, there are no exclusion criteria.

结局指标

主要结局

Overall intensity of the symptoms

时间窗: Retrospective analysis over three months

Subjects will be asked to complete an online questionnaire assessing the overall intensity of their symptoms over the past three months, using a 4-point scale (0-no symptoms to 4-severe symptoms).

Coolness or soothing effect

时间窗: Retrospective analysis over three months

Subjects will be asked to complete an online questionnaire assessing their experience with the product over the past three months, using a 7-point scale (0-strongly disagree to 7-strongly agree).

Symptoms relief (skin irritation, pain, dryness)

时间窗: Retrospective analysis over three months

Subjects will be asked to complete an online questionnaire assessing their experience with the product over the past three months, using a 7-point scale (0-strongly disagree to 7-strongly agree).

次要结局

  • Descriptive summary of product usage: frequency, reasons, and ease of use(Retrospective analysis over three months)

研究者

发起方
Bayer
申办方类型
Industry
责任方
Sponsor

研究点 (1)

Loading locations...

相似试验